Table 1 |
|||
| Clinic characteristics of the three groups of patients | |||
| Group A (n = 40) | Group B (n = 34) | Group C (n = 20) | |
| Sex (male/female) | 20/20 | 17/17 | 12/8 |
| Age (years) | 45.50 ± 14.82 | 46.79 ± 13.62 | 24.95 ± 14.10 |
| Time to biopsy (days) | 113.90 ± 105.46 | 55.03 ± 63.67 | 59.85 ± 78.60 |
| Steroid treatment (%) | 100 | 0 | 65 |
| MAP (mmHg) | 94.45 ± 10.00 | 92.78 ± 10.81 | 88.42 ± 10.23 |
| Hematuria (%) | 0 | 0 | 5 |
| Proteinuria (g/24 h) | 5.80 ± 3.15 | 4.21 ± 2.37 | 3.72 ± 3.47 |
| SCr(umol/L) | 74.89 ± 26.42 | 59.34 ± 13.03 | 77.01 ± 37.94 |
| BUN(mmol/L) | 5.27 ± 1.59 | 3.89 ± 1.06 | 5.37 ± 1.88 |
Group A: patients treated with corticosteroid before biopsy.
Group B: patients treated without corticosteroid before biopsy.
Group C: patients with mild mesangioproliferative glomerulonephritis.
Zhang et al. Diagnostic Pathology 2012 7:109 doi:10.1186/1746-1596-7-109
